Stem cells, exosomes, gene therapy, peptides, hyperbaric oxygen, and epigenetic reprogramming
390 artigos
A new Nature Biotechnology review maps how large-scale AI foundation models are transforming biomedicine, from genomics to clinical diagnostics.
Scientists built the first in vitro menstrual cycle using organoids, uncovering WNT7A as a key driver of scarless endometrial regeneration.
Embryonic brain precursor cells grafted into adult rat striatum successfully integrate and reduce motor deficits in a Parkinson's disease model.
Vá além do básico para entender as enzimas, as vias de sinalização e o crosstalk celular que governam como sua matriz extracelular envelhece — e o que os pesquisadores estão fazendo a respeito.
Next-gen CAR-T approaches skip the lab and engineer immune cells directly inside the body, potentially making cancer therapy faster and cheaper.
Descubra o arcabouço invisível que mantém seu corpo unido — e por que preservá-lo saudável é uma das fronteiras mais empolgantes da ciência da longevidade.
A comprehensive review reveals how biomaterials, stem cells, and 3D bioprinting are converging to restore damaged endometrial tissue and treat infertility.
Intellia's in vivo CRISPR treatment edits genes directly inside living patients and just cleared a Phase 3 trial — a world first.
Intellia Therapeutics reports a landmark Phase 3 win for CRISPR gene editing, potentially offering a one-time cure for a debilitating genetic disease.
Single-cell sequencing reveals ferroptosis drives pulpitis; thymosin α1 restores GPX4, cuts iron overload, and reduces inflammation in cells and rats.
Engineered immune cells simultaneously dissolve cardiac fibrosis and rebuild heart muscle in mice, offering a dual-action therapy for heart failure.
Scientists discover muscle cells bypass normal nuclear pores to export oversized RNA transcripts via a newly identified budding pathway.
